###begin article-title 0
###xml 80 81 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 86 87 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells
###end article-title 0
###begin p 1
M. Sarfati and D. Franchimont contributed equally to this paper.
###end p 1
###begin p 2
###xml 51 52 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 161 162 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 280 281 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 338 339 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 573 574 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 579 580 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 783 784 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 789 790 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 905 906 873 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 911 912 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1118 1119 1082 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1124 1125 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1222 1223 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1228 1229 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 1178 1182 <span type="species:ncbi:10090">mice</span>
Mesenteric lymph node (mLN) CD103 (alphaE integrin)+ dendritic cells (DCs) induce regulatory T cells and gut tolerance. However, the function of intestinal CD103- DCs remains to be clarified. CD47 is the ligand of signal regulatory protein alpha (SIRPalpha) and promotes SIRPalpha+ myeloid cell migration. We first show that mucosal CD103- DCs selectively express SIRPalpha and that their frequency was augmented in the lamina propria and mLNs of mice that developed Th17-biased colitis in response to trinitrobenzene sulfonic acid. In contrast, the percentage of SIRPalpha+CD103- DCs and Th17 responses were decreased in CD47-deficient (CD47 knockout [KO]) mice, which remained protected from colitis. We next demonstrate that transferring wild-type (WT), but not CD47 KO, SIRPalpha+CD103- DCs in CD47 KO mice elicited severe Th17-associated wasting disease. CD47 expression was required on the SIRPalpha+CD103- DCs for efficient trafficking to mLNs in vivo, whereas it was dispensable on both DCs and T cells for Th17 polarization in vitro. Finally, administration of a CD47-Fc molecule resulted in reduced SIRPalpha+CD103- DC-mediated Th17 responses and the protection of WT mice from colitis. We thus propose SIRPalpha+CD103- DCs as a pathogenic DC subset that drives Th17-biased responses and colitis, and the CD47-SIRPalpha axis as a potential therapeutic target for inflammatory bowel disease.
###end p 2
###begin p 3
###xml 381 394 381 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Iwasaki, 2007</xref>
###xml 416 417 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 630 660 630 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Johansson-Lindbom et al., 2005</xref>
###xml 662 679 662 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Jang et al., 2006</xref>
###xml 740 760 740 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Coombes et al., 2007</xref>
###xml 762 783 762 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Jaensson et al., 2008</xref>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 897 898 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 902 903 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 920 921 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 925 926 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 931 932 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 946 966 946 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Coombes et al., 2007</xref>
###xml 968 984 968 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Sun et al., 2007</xref>
###xml 1000 1001 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1086 1087 1086 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1129 1149 1129 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Denning et al., 2007</xref>
###xml 1151 1172 1151 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Atarashi et al., 2008</xref>
###xml 1188 1189 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1335 1336 1335 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1410 1434 1410 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Coombes and Powrie, 2008</xref>
DCs are located throughout mucosal surfaces and orchestrate the delicate balance between tolerance to innocuous antigens and the generation of protective immune responses upon exposure to pathogens. Different DC subsets populate the gut mucosa and mesenteric lymph nodes (mLNs), and their functions vary according to their anatomical location and conditioning by epithelial cells (Iwasaki, 2007). For instance, CD103+ and CD103- DC subsets isolated from mLNs display distinct phenotypes and cytokine profiles. A substantial proportion of CD103+ DCs continuously emigrate from the intestine to the mLNs in a CCR7-dependent manner (Johansson-Lindbom et al., 2005; Jang et al., 2006), where they represent from 40 to 70% of the DC population (Coombes et al., 2007; Jaensson et al., 2008). Under steady-state conditions, mLN CD103+ DCs are prone, in the presence of retinoic acid, to convert naive CD4+CD25- T cells into CD4+CD25+Foxp3+ T reg cells (Coombes et al., 2007; Sun et al., 2007), whereas CD103- DCs isolated from the mLNs and lamina propria (LP) of the small intestine express CX3CR1 and drive Th17 polarization in vitro (Denning et al., 2007; Atarashi et al., 2008). The mLN CD103- DCs appear to be directly derived from blood-borne precursors; express Toll-like receptor (TLR) 2, TLR4, and TBX21 to a greater extent than CD103+ DCs; and secrete high levels of TNF and IL-6 in response to stimulation (Coombes and Powrie, 2008). However, little is known about the precise contribution of each of these DC subsets during the development of intestinal inflammation.
###end p 3
###begin p 4
###xml 235 244 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Cho, 2008</xref>
###xml 536 549 536 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Kelsall, 2008</xref>
###xml 740 766 736 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib70">Sanchez-Munoz et al., 2008</xref>
###xml 928 944 914 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Trinchieri, 1993</xref>
###xml 946 967 932 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Bettelli et al., 2007</xref>
Crohn's disease (CD) is a chronic, relapsing, T cell-driven inflammatory disease of the gastrointestinal tract thought to result from inappropriate mucosal immune responses to commensal bacteria in genetically susceptible individuals (Cho, 2008). DCs have been implicated in CD pathogenesis, because dysregulation in DC-epithelial cell interactions, defective migration and function of tolerogenic DCs, and/or aberrant immunogenic DC responses to pathogens have been proposed to participate in the induction of intestinal inflammation (Kelsall, 2008). Once initiated, the inflamed tissue is characterized by the expression of innate (IL-6, IL-12, TNF, and IL-23) and adaptive-derived (IL-6, IFN-gamma, and IL-17) proinflammatory cytokines (Sanchez-Munoz et al., 2008). Antigen-presenting cell-derived TGF-beta, IL-1beta, IL-6, and IL-23 drive Th17 responses, whereas IL-12 and IFN-gamma promote Th1 and suppress Th17 responses (Trinchieri, 1993; Bettelli et al., 2007).
###end p 4
###begin p 5
###xml 461 482 461 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">te Velde et al., 2006</xref>
###xml 656 679 656 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Annunziato et al., 2007</xref>
###xml 681 703 681 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Sheibanie et al., 2007</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
Trinitrobenzene sulfonic acid (TNBS)-induced colitis is a mouse model of intestinal inflammation sharing many key features with human CD. TNBS administration first induces acute inflammation, characterized by the infiltration of neutrophils and macrophages, followed by antigen-specific priming of T cells. Challenge with a second dose of TNBS provokes a T cell-predominant reaction associated with tissue damage and mimics the chronic inflammation seen in CD (te Velde et al., 2006). Although classically considered a Th1 disease, the recently identified Th17 cell lineage appears to play an important role in the development of both TNBS colitis and CD (Annunziato et al., 2007; Sheibanie et al., 2007).
###end p 5
###begin p 6
###xml 125 162 125 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">van den Berg and van der Schoot, 2008</xref>
###xml 335 352 335 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Reed et al., 1993</xref>
###xml 419 438 419 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Armant et al., 1999</xref>
###xml 552 570 552 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Avice et al., 2000</xref>
###xml 703 727 703 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Bouguermouh et al., 2008</xref>
###xml 911 929 903 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams et al., 1998</xref>
###xml 931 953 923 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">Ticchioni et al., 2001</xref>
###xml 1114 1130 1106 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 1246 1247 1234 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1287 1288 1271 1272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1293 1294 1277 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 452 457 <span type="species:ncbi:9606">human</span>
CD47, a marker of self on immune and nonimmune cells, is implicated at several levels in the generation of immune responses (van den Berg and van der Schoot, 2008). On the one hand, ligation of CD47 by the extracellular matrix protein thrombospondin-1, which is abundantly and rapidly expressed in tissues in response to inflammation (Reed et al., 1993), down-regulates IL-12p70 production by antigen-presenting cells (Armant et al., 1999) and impairs human naive T cell differentiation to Th1 cells in vitro without any immune deviation to Th2 cells (Avice et al., 2000). Recent data have also shown that CD47 expression on T cells is a self-control negative regulator of Th1 immune responses in vivo (Bouguermouh et al., 2008). On the other hand, CD47 interacts with signal regulatory protein alpha (SIRPalpha), its counterreceptor, which is selectively expressed on myeloid, endothelial, and neuronal cells (Adams et al., 1998; Ticchioni et al., 2001). The expression of CD47 on epidermal and dermal DCs promotes their migration to draining lymph nodes, where T cell priming and immune responses are initiated (Van et al., 2006). We first show that SIRPalpha is selectively expressed on one of the two major mucosal DC subsets, i.e., the CD103- DCs. We next demonstrate that SIRPalpha+CD103- DCs are the primary immunogenic DC subset involved in the development and perpetuation of Th17-associated TNBS-induced colitis, and that their migration is controlled by CD47.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
###xml 24 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 30 31 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
CD47 regulates SIRPalpha+CD103- DC homeostasis in the LP and mLNs of naive and TNBS-treated mice
###end title 8
###begin p 9
###xml 229 230 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 238 254 234 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Liu et al., 2002</xref>
###xml 256 272 252 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 379 380 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 390 391 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 478 479 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 484 485 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 510 525 498 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and B</xref>
###xml 748 749 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 754 755 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 839 854 823 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and B</xref>
###xml 1054 1055 1034 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1060 1061 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1134 1135 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1140 1141 1116 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1211 1226 1187 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and C</xref>
###xml 1253 1254 1225 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1259 1260 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1353 1368 1325 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, B and D</xref>
###xml 1417 1418 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1423 1424 1391 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1518 1533 1486 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, C and D</xref>
###xml 1602 1603 1566 1567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1608 1609 1572 1573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1832 1833 1792 1793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1838 1839 1798 1799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2132 2133 2088 2089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2138 2139 2094 2095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2153 2154 2105 2106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2159 2160 2111 2112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2306 2307 2254 2255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2312 2313 2260 2261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
###xml 1307 1311 <span type="species:ncbi:10090">mice</span>
###xml 1453 1457 <span type="species:ncbi:10090">mice</span>
###xml 1512 1516 <span type="species:ncbi:10090">mice</span>
###xml 1951 1955 <span type="species:ncbi:10090">mice</span>
###xml 2050 2054 <span type="species:ncbi:10090">mice</span>
###xml 2190 2194 <span type="species:ncbi:10090">mice</span>
Multiple DC subpopulations have been identified and characterized by their expression of CD11c, CD11b, and CD103 in the intestinal LP and mLNs. Because CD47 has previously been shown to regulate cell migration of innate SIRPalpha+ cells (Liu et al., 2002; Van et al., 2006), we first thought to examine the expression of SIRPalpha on the two major mucosal DC subsets, i.e., CD103+ and CD103- DCs. We found that SIRPalpha was preferentially expressed with high intensity on CD11b+CD103- DCs in the LP and mLNs (Fig. 1, A and B). To investigate the dynamic regulation of these DC subsets during inflammation, their distribution profiles were assessed at steady state and in response to TNBS challenge. We observed an increased percentage of SIRPalpha+CD103- DCs in the LP as well as in the mLNs after the intrarectal administration of TNBS (Fig. 1, A and B), suggesting a role for this DC subset in the response to hapten-induced colonic inflammation. We next used CD47 KO mice to examine the potential role of CD47 in modulating the frequency of SIRPalpha+CD103- DCs in the LP and mLNs. Although no significant differences in SIRPalpha+CD103- DC proportions were observed in the LP of naive WT and CD47 KO mice (Fig. 1, A and C), a reduction in SIRPalpha+CD103- DCs was observed in the mLNs of naive CD47 KO mice when compared with their WT littermates (Fig. 1, B and D). Upon TNBS challenge, the increase in SIRPalpha+CD103- DCs normally observed in WT mice did not occur in either the LP or the mLNs of CD47 KO mice (Fig. 1, C and D), suggesting that CD47 is required for the mobilization of SIRPalpha+CD103- DCs in response to TNBS challenge. Although we show results from mLNs on day 2 after TNBS instillation, similar data were observed on day 4 and in caudal lymph nodes (unpublished data). Notably, the proportion of SIRPalpha-CD103+ DCs, which have been shown to promote tolerance, were not increased in the LP of either strain of TNBS-treated mice. However, their frequency was strongly reduced in the mLNs of WT but not CD47 KO TNBS-treated mice (). Of note, the intensity of CD47 expression was identical between SIRPalpha+CD103- and SIRPalpha-CD103+ DCs in the LP and mLNs of WT mice (unpublished data). Collectively, our results suggest that CD47 regulates the mobilization of mucosal SIRPalpha+CD103-DCs in response to inflammation and, thus, may play a role in gut DC homeostasis.
###end p 9
###begin p 10
###xml 24 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 30 31 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 0 65 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD47 regulates SIRP&#945;<sup>+</sup>CD103<sup>&#8722;</sup> DC homeostasis in the LP and mLNs</bold>
###xml 124 125 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 130 132 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 398 399 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 404 405 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 422 423 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 428 430 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
CD47 regulates SIRPalpha+CD103- DC homeostasis in the LP and mLNs. (A-D) CD11b, CD103, and SIRPalpha expression among CD45.2+CD11cHi DCs at steady state (control; top) and 2 d after intrarectal administration of 3 mg TNBS (TNBS; bottom) in the LP (A and C) and mLNs (B and D) of WT (A and B) and CD47 KO (C and D) mice. Data shown are one representative mouse per group. (E) Percentage of SIRPalpha+CD103- DCs among CD45.2+CD11cHi DCs in the LP (left) and mLNs (right). Data represent the means +/- SEM of more than eight mice per group. Each experiment was independently performed a minimum of four times. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
###end p 10
###begin title 11
CD47 ablation ameliorates the development of chronic TNBS colitis
###end title 11
###begin p 12
###xml 68 69 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 75 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 381 389 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 533 541 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 973 988 969 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, B and D</xref>
###xml 1220 1235 1216 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, C and E</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
We therefore hypothesized that the increased proportion of SIRPalpha+CD103- DCs in the LP and mLNs of WT mice would be correlated with colitis development, in which case CD47 KO mice would be protected from disease. Analysis of body weight loss as early as day 2 after primary TNBS instillation revealed a significant reduction of wasting disease in CD47 KO compared with WT mice (Fig. 2 A). This protection was enhanced daily until day 8, by which time CD47 KO, as opposed to WT mice, had fully regained their original body weight (Fig. 2 A). To evaluate the degree of colonic inflammation, both the macroscopic and histological scores of tissue damage were assessed. Colons from WT mice with TNBS colitis displayed shortening and thickening, with patchy areas of severe ulceration and prominent adhesions typical of this form of colitis. On the contrary, CD47 KO mice developed fewer of these characteristics and displayed significantly milder inflammation than WT mice (Fig. 2, B and D). Upon histological assessment, we confirmed that colons from WT mice with colitis exhibited a substantial infiltration with mononuclear cells, edema, and loss of goblet cells, whereas CD47 KO mice were resistant to these changes (Fig. 2, C and E).
###end p 12
###begin p 13
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD47 ablation protects from the development of TNBS colitis.</bold>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
CD47 ablation protects from the development of TNBS colitis. TNBS colitis was induced on day 0 alone or on days 0 and 7 (circled). (A) Weight loss curves of WT and CD47 KO mice injected intrarectally with saline (control), ethanol alone, or TNBS dissolved in 50% ethanol on day 0. (B-E) Macroscopic (B and D) and histological (C and E) analyses of inflammation in WT and CD47 KO mice. Data represent means +/- SEM of more than eight mice per group, and one representative experiment out of three is shown. (F) Weight loss curves of WT and CD47 KO mice injected intrarectally with 2 mg TNBS dissolved in 50% ethanol on days 0 and 7. (G and H) Macroscopic (G) and histological (H) analyses of inflammation in WT and CD47 KO mice after reinduction of TNBS colitis. Data represent means +/- SEM of six mice per group. One representative experiment out of three is shown. *, P < 0.05; **, P < 0.01.
###end p 13
###begin p 14
###xml 390 398 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 G</xref>
###xml 441 449 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 H</xref>
###xml 628 629 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 634 635 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 234 239 <span type="species:ncbi:9606">human</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
We next confirmed the disease resistance of CD47 KO mice in a reactivated form of colitis, where a second instillation of TNBS was administered 7 d after the primary instillation. This model is said to mimic the relapsing behavior of human CD. Here, upon reinduction of TNBS colitis, CD47 KO mice remained resistant to body weight loss, whereas WT mice displayed severe wasting once again (Fig. 2 F). Macroscopic (Fig. 2 G) and microscopic (Fig. 2 H) scores confirmed that CD47 KO mice were largely devoid of signs of chronic colonic inflammation. Collectively, our data demonstrate that the CD47-dependent increase in SIRPalpha+CD103- DCs in the LP and mLNs is correlated with the development of chronic intestinal inflammation.
###end p 14
###begin title 15
CD47 ablation impairs Th17 responses in vivo
###end title 15
###begin p 16
###xml 348 356 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 530 538 527 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 687 695 681 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 839 847 829 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 1108 1116 1090 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
The chronic stage of TNBS colitis is driven by an important interplay between the innate and adaptive immune systems. We sought to further characterize this inflammation in WT and CD47 KO mice. Both on day 8 and after reinduction of TNBS colitis, a strong up-regulation of IL-6 mRNA expression was observed in WT but not in protected CD47 KO mice (Fig. 3 A). The same trend, but of a lesser magnitude, was observed for TGF-beta, IL-12p35, and IL-23p19, where mRNA expression was increased in TNBS-treated WT but not CD47 KO mice (Fig. 3 A). Corroborating the increase in IL-6 and TGF-beta expression, IL-17 mRNA was highly up-regulated at both time points in WT but not in CD47 KO mice (Fig. 3 B). IFN-gamma mRNA expression was greater in CD47 KO than WT mice, but only on day 8, with no significant difference observed after reinduction (Fig. 3 B). Interestingly, although both forms of colitis displayed qualitatively and quantitatively distinct IL-17 and IFN-gamma mRNA expression profiles, the IL-17/IFN-gamma mRNA expression ratios were nearly identical, with both being higher in WT than CD47 KO mice (Fig. 3 C). We therefore chose to focus on the reinduction model of colitis for the rest of this study because it more accurately reflects the chronic relapsing behavior of CD.
###end p 16
###begin p 17
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decreased proinflammatory cytokine and Th17-biased responses in CD47 KO mice.</bold>
###xml 609 610 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 623 624 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 646 647 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 684 685 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 695 696 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 712 713 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Decreased proinflammatory cytokine and Th17-biased responses in CD47 KO mice. (A-C) Colonic mRNA expression of cytokines. (A) Colonic IL-6, IL-12p35, TGF-beta, and IL-23p19 mRNA expression. (B) Colonic IL-17 and IFN-gamma mRNA expression. (C) Ratio of colonic IL-17/IFN-gamma mRNA expression. Data represent mean fold changes relative to WT control +/- SEM of more than eight mice per group (two independent experiments). (D) mLNs were isolated after reinduction of TNBS colitis and stimulated for 4 d in the presence of IL-23. Intracytoplasmic staining was performed after restimulation. The percentage IL-17+ or IFN-gamma+ cells among total CD4+ T cells is shown. (E) Ratio of IL-17+/IFN-gamma+ cells among CD4+ T cells. Data represent the mean percentages +/- SEM of more than seven mice per group (two independent experiments). *, P < 0.05; **, P < 0.01.
###end p 17
###begin p 18
###xml 477 485 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 788 789 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 819 827 811 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 864 865 856 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 875 876 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 983 991 971 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 1108 1130 1096 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Sheibanie et al., 2007</xref>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
We next postulated that the reduction in IL-17-associated cytokines in colon tissues was partly attributable to an impaired capacity to generate IL-17-producing T cells (Th17 cells) in the mLNs of CD47 KO mice. Therefore, we examined IFN-gamma and IL-17 production in 4-d cultures of mLNs isolated from mice with chronic TNBS colitis. Analysis by flow cytometry revealed that the percentage of Th17 cells was significantly higher in WT compared with CD47 KO mice with colitis (Fig. 3 D). Similar data were observed by measuring IL-17 production in the culture supernatants by ELISA or by examining IL-17 expression in mLN cells after 6 h of PMA/ionomycin restimulation (unpublished data). Under these pro-Th17 culture conditions, no significant difference was observed with respect to CD4+ T cells producing IFN-gamma (Fig. 3 D). When expressed as a ratio of IL-17+/IFN-gamma+ cells, CD47 KO mice exposed to TNBS displayed a significantly reduced propensity toward IL-17 production (Fig. 3 E), corroborating with tissue mRNA expression and the recent shift in the Th1/Th17 paradigm reported in TNBS colitis (Sheibanie et al., 2007). Thus, CD47 ablation impairs the induction and perpetuation of colitis associated with a Th17-biased response in mLNs.
###end p 18
###begin title 19
###xml 9 10 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 16 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
SIRPalpha+CD103- DCs promote Th17 responses in vitro
###end title 19
###begin p 20
###xml 81 82 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 87 88 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 219 220 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 225 226 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 240 241 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 246 247 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 344 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 409 410 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 415 416 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 455 456 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 461 462 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 504 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 514 529 494 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, A and B</xref>
###xml 656 657 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 662 663 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 683 691 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
To establish causative links between the increased frequency of mucosal SIRPalpha+CD103- DCs and Th17 responses observed in vivo, we first sought to assess the in vitro Th1- versus Th17-promoting capacities of SIRPalpha+CD103- and SIRPalpha-CD103+ DCs. These two DC subpopulations were isolated from the LP and mLNs () and co-cultured with CD4+ T cells from the same anatomical origin. We found that SIRPalpha+CD103- DCs were more efficient than SIRPalpha-CD103+ DCs at promoting IL-17 production by CD4+ T cells (Fig. 4, A and B). Interestingly, DCs purified from spleens behaved in a very similar manner as those isolated from LP and mLNs, with SIRPalpha+CD103- DCs favoring Th17 (Fig. 4 C).
###end p 20
###begin p 21
###xml 9 10 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 16 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 0 53 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIRP&#945;<sup>+</sup>CD103<sup>&#8722;</sup> DCs promote Th17 responses in vitro.</bold>
###xml 83 84 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 89 90 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 104 105 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 110 111 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 131 133 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 323 324 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 460 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 465 466 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 480 481 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 486 487 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 509 510 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 556 557 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 684 685 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 695 696 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 718 719 690 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 774 775 742 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 780 781 748 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 794 795 758 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 800 801 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 818 819 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 824 825 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
SIRPalpha+CD103- DCs promote Th17 responses in vitro. (A-C) Percentage of SIRPalpha+CD103- and SIRPalpha-CD103+ DCs (gated on CD11cHi; left) and their IFN-gamma- versus IL-17-promoting capacities (middle and right) when isolated from the LP (A), mLNs (B), or spleen (C) and co-cultured with purified anti-CD3-stimulated CD4+ T cells of the same anatomical origin. Dot plots represent one independent experiment out of two or three. (D) Percentage of SIRPalpha+CD103- and SIRPalpha-CD103+ BMDCs (gated on CD11c+; left) and co-culture with OVA-stimulated CD4+ transgenic T cells under Th17-polarizing conditions (right). Data represent one independent experiment out of three. (E) IL-17+/IFN-gamma+ cell ratio (among CD4+ T cells) after co-culture with either sorted SIRPalpha+CD103- or SIRPalpha-CD103+ DCs or SIRPalpha+CD103- BMDCs. The data of sorted cells represents mean of all sources of DCs (LP, mLNs, and spleen) +/- SEM of a minimum of three independent experiments. *, P < 0.05.
###end p 21
###begin p 22
###xml 223 224 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 229 230 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 309 317 301 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 339 340 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 345 346 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 383 384 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 389 390 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 435 436 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 527 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 532 533 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 539 547 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 586 587 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 592 593 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 611 612 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 617 618 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
When bone marrow-derived DCs (BMDCs) that express SIRPalpha (>99%) but not CD103 (<1%) were co-cultured with naive transgenic T cells under Th17-promoting conditions, they elicited a similar Th17-biased profile as SIRPalpha+CD103- mLN DCs, suggesting that these properties are not limited to gut-derived DCs (Fig. 4 D). Moreover, SIRPalpha+CD103- mucosal or splenic DCs and SIRPalpha+CD103- BMDCs induced statistically equivalent IL-17+/IFN-gamma+ ratios, both of which were significantly higher compared with sorted SIRPalpha-CD103+ DCs (Fig. 4 E). Therefore, we propose that SIRPalpha+CD103- but not SIRPalpha-CD103+ DCs possess Th17-promoting properties in vitro.
###end p 22
###begin title 23
###xml 21 22 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 28 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Transfer of SIRPalpha+CD103- BMDCs induces colitis and promotes a Th17 response in CD47 KO mice
###end title 23
###begin p 24
###xml 61 62 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 68 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 197 198 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 203 204 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 380 410 372 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Johansson-Lindbom et al., 2003</xref>
###xml 412 429 404 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Kool et al., 2008</xref>
###xml 594 595 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 609 628 601 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Robert et al., 2003</xref>
###xml 630 651 622 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Cavanagh et al., 2005</xref>
###xml 767 775 759 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1137 1145 1129 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1215 1223 1207 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1242 1250 1234 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1419 1423 <span type="species:ncbi:10090">mice</span>
To directly examine the proinflammatory capacity of SIRPalpha+CD103- DCs in vivo and the role of CD47 on the DCs for disease induction, CD47 KO mice were administered mature WT or CD47 KO SIRPalpha+CD103- BMDCs on the day of colitis induction. BMDCs were injected i.p. because previous reports have shown that the mLNs drain the peritoneal cavity, in addition to the gut tissues (Johansson-Lindbom et al., 2003; Kool et al., 2008). Moreover, the i.v. route was deemed unsuitable because i.v.-injected BMDCs migrate very poorly to the LNs, even when administered at high concentrations (3-8 x 106 BMDCs/mouse; Robert et al., 2003; Cavanagh et al., 2005). Upon reinduction of TNBS colitis on day 8, CD47 KO mice injected with WT BMDCs developed severe wasting disease (Fig. 5 A), indicating that CD47 expression was not required in the host for colitis development. Injection of WT BMDCs had no effect on disease outcome when injected in WT mice (). In contrast to WT BMDCs, injection of CD47 KO BMDCs in CD47 KO hosts appeared to induce only a mild form of inflammation that resulted in a slight, nonsignificant reduction of body weight (Fig. 5 A). The changes in body weight were reflected both in the macroscopic (Fig. 5 B) and microscopic (Fig. 5 C) extent of inflammation, with WT BMDC injection resulting in an aggressive form of disease. Notably, injection of WT BMDCs also increased the mortality rate of CD47 KO mice more than injection of CD47 KO BMDCs (uninjected, <5%; CD47 KO BMDCs, 25%; and WT BMDCs, 45%).
###end p 24
###begin p 25
###xml 28 29 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 35 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 0 111 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD47 expression on SIRP&#945;<sup>+</sup>CD103<sup>&#8722;</sup> DCs promotes the development of intestinal inflammation and Th17 responses.</bold>
###xml 837 838 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 851 852 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 856 857 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 888 889 872 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 899 900 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 916 917 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
CD47 expression on SIRPalpha+CD103- DCs promotes the development of intestinal inflammation and Th17 responses. CD47 KO mice were injected i.p. with saline or WT or CD47 KO BMDCs 30 min before the induction of TNBS colitis on day 0. TNBS was reinduced on day 8. (A) Weight-loss curves after transfer of WT or CD47 KO BMDCs in CD47 KO hosts and reinduction of TNBS colitis, normalized to body weight on day 8. (B and C) Macroscopic (B) and histological (C) appearance of colonic inflammation. Images are of one representative mouse per experimental group. (D) Colonic mRNA expression of IL-17 and IFN-gamma and IL-17/IFN-gamma mRNA expression ratio. Data represent the mean fold changes relative to control. (E) mLNs were isolated after reinduction of TNBS colitis and stimulated for 4 d in the presence of IL-23. The percentages of IL-17+ or IFN-gamma+ CD4+ T cells and the ratio of IL-17+/IFN-gamma+ cells among CD4+ T cells are shown. Data represent means +/- SEM of more than five mice per group (two pooled independent experiments). *, P < 0.05; ***, P < 0.001.
###end p 25
###begin p 26
###xml 347 355 343 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 453 461 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 669 670 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 674 675 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 734 735 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 745 746 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 750 751 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 766 781 754 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, E and F</xref>
###xml 937 952 921 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, E and F</xref>
###xml 973 974 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 979 980 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1335 1336 1311 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1341 1342 1317 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1520 1521 1492 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1526 1527 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
We next examined whether disease development after WT BMDC injection was associated with the induction of Th17-biased responses in CD47 KO hosts. Injection of WT BMDCs significantly enhanced the colonic mRNA expression of IL-17 but not IFN-gamma, whereas injection of CD47 KO BMDCs had no effect on the colonic mRNA expression of either cytokine (Fig. 5 D). Therefore, only WT BMDCs resulted in a significant increase in the IL-17/IFN-gamma mRNA ratio (Fig. 5 D). To verify whether the induction of colonic IL-17 mRNA expression was linked to an increase in Th17 cells, we examined the mLNs of reconstituted mice. Injection of WT BMDCs increased the proportion of IL-17+ CD4+ T cells, leading to a significant enhancement in the IL-17+/IFN-gamma+ CD4+ T cell ratio (Fig. 5, E and F). On the other hand, injection of CD47 KO BMDCs elicited IL-17 expression that did not translate into a significant increase in the IL-17/IFN-gamma ratio (Fig. 5, E and F). Finally, SIRPalpha+CD103- DCs purified from WT mLNs and injected i.p. were also capable of inducing severe wasting disease, resulting in 25% mortality after a single dose of TNBS in CD47 KO mice (). Severe weight loss in these mice was correlated with pronounced colonic inflammation and Th17-polarized responses, corroborating the similar in vitro pro-Th17 responses of SIRPalpha+CD103- BMDCs and mucosal DCs. These data demonstrate that CD47 expression is dispensable on the endothelium, epithelium, and T cells of the host but appears to be critical on SIRPalpha+CD103- DCs for Th17-associated colonic disease induction in vivo.
###end p 26
###begin title 27
###xml 9 10 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 16 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
SIRPalpha+CD103- DC trafficking but not phenotype or function is governed by CD47
###end title 27
###begin p 28
###xml 80 81 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 86 87 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 559 574 555 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A and B</xref>
###xml 630 631 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 636 637 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 718 724 710 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
We next sought to delineate the mechanisms by which CD47 expression on SIRPalpha+CD103- BMDCs controls the development of Th17 responses and colonic inflammation. To this end, we evaluated the in vivo migratory properties and the in vitro function of WT and CD47 KO BMDCs. First, WT and CD47 KO BMDCs were fluorescently labeled and injected i.p. at a 1:1 ratio in CD47 KO mice and retraced in the mLNs after 2 d. By using this competitive migration assay, we provide evidence that CD47 expression on BMDCs significantly favors their accumulation in the mLNs (Fig. 6, A and B), corroborating the increased mobilization of SIRPalpha+CD103- mucosal DCs observed in WT but not CD47 KO mice upon induction of TNBS colitis (Fig. 1).
###end p 28
###begin p 29
###xml 24 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 30 31 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 0 77 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD47 regulates SIRP&#945;<sup>+</sup>CD103<sup>&#8722;</sup> DC trafficking but not phenotype or function.</bold>
###xml 252 253 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 350 351 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 513 514 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 597 598 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 981 982 967 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1036 1037 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1054 1055 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1149 1150 1135 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1266 1267 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 1314 1318 <span type="species:ncbi:10090">mice</span>
CD47 regulates SIRPalpha+CD103- DC trafficking but not phenotype or function. (A, left) 1:1 ratio of labeled BMDCs before injection on day 0. (middle and right) TNBS colitis was induced in CD47 KO mice, and mLNs were harvested after 2 d. (middle) CD11c+ DCs in the mLNs of uninjected CD47 KO mice. (right) Labeled WT and CD47 KO BMDCs (gated on CD11c+) in the mLNs of BMDC-injected CD47 KO mice. One representative mouse is shown for each condition. (B) Percentages of labeled WT and CD47 KO BMDCs (gated on CD11c+) in the mLNs of CD47 KO mice. Data were generated in two independent experiments (n = 8). (C and D) Analysis of phenotype (C) and activation status (D) of LPS-stimulated BMDCs. The numbers in brackets in C represent the mean fluorescence intensity of SIRPalpha. Data are representative of three independent experiments. (E) Cytokine production by BMDCs stimulated overnight with LPS (0-100 ng/ml) and IFN-gamma (10 ng/ml) in vitro. Data represent the means +/- SEM (n = 4 independent experiments). (F) Percentage of IL-17+ cells (among CD4+ T cells) after criss-cross co-cultures with anti-CD3-stimulated WT versus CD47 KO splenic CD4+ T cells and LPS-stimulated WT versus CD47 KO BMDCs under Th17-polarizing conditions. Data represent means +/- SEM (n = 3 independent experiments with two to three mice per experimental group).
###end p 29
###begin p 30
###xml 165 173 161 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 339 347 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 472 480 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
###xml 769 784 761 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, E and F</xref>
###xml 879 880 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1040 1048 1032 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 F</xref>
###xml 1174 1175 1162 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1180 1181 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1233 1234 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1239 1240 1223 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Next, we assessed the phenotype of BMDCs in terms of their expression of CD11c, CD11b, SIRPalpha, and CD103 and observed no difference between WT and CD47 KO BMDCs (Fig. 6 C). Importantly, the level of expression of SIRPalpha was not altered on a per-cell basis by the expression of CD47, as determined by its mean fluorescence intensity (Fig. 6 C). The surface expression of MHC II and the co-stimulatory molecules CD40 and CD86 were also independent of CD47 expression (Fig. 6 D). We next examined the function of WT and CD47 KO BMDCs by measuring the production of cytokines such as IL-6 and IL-23p19, as well as their ability to drive Th17 polarization. Both cytokine production and Th17-promoting capacity were found to be unrelated to CD47 expression on the DCs (Fig. 6, E and F). Also, lack of CD47 expression on T cells did not alter the percentage of IL-17-producing CD4+ T cells, thereby eliminating the possibility of a T cell-intrinsic defect in Th17 polarization in CD47 KO T cells as a mechanism for decreased Th17 responses (Fig. 6 F). Because CD47 does not alter the phenotype, activation status, cytokine production, or Th17-polarizing capacity of SIRPalpha+CD103- BMDCs, we propose that CD47 expression on SIRPalpha+CD103- DCs is critical for their trafficking to mLNs, a property mechanistically related to the ensuing Th17 responses and colitis development.
###end p 30
###begin title 31
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Administration of CD47-Fc ameliorates disease development in BALB/c mice
###end title 31
###begin p 32
###xml 164 165 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 170 171 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 368 376 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 547 555 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 753 764 745 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A&#8211;C</xref>
###xml 1031 1039 1023 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 D</xref>
###xml 1082 1083 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1089 1076 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1159 1167 1147 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 E</xref>
###xml 1362 1370 1342 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 F</xref>
###xml 1544 1552 1520 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 G</xref>
###xml 1798 1799 1770 1771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1804 1805 1776 1777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">Mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1695 1699 <span type="species:ncbi:10090">mice</span>
Finally, we circumvented the multiple defects of CD47 KO hosts and directly examined the impact of targeting the SIRPalpha-CD47 axis on the recruitment of SIRPalpha+CD103- DCs in mLNs, Th17 polarization, and the development of chronic colitis in WT mice. To this end, BALB/c mice were administered a CD47-Fc molecule i.p. 30 min before TNBS injection and on days 1-3 (Fig. 7 A, arrows). Mice administered CD47-Fc were largely protected from colonic inflammation as assessed by body weight, starting as early as 1 d after the induction of colitis (Fig. 7 A). Furthermore, CD47-Fc-treated mice remained resistant to colitis even after a second induction of TNBS colitis, as demonstrated by a reduction in body weight loss and the extent of tissue damage (Fig. 7, A-C). Injection of a control human CD47-Fc with no cross-reactivity in mice did not ameliorate disease (not depicted). Serum levels and colonic mRNA expression of IL-6 were determined early in disease onset (day 4) and were dramatically reduced in CD47-Fc-treated mice (Fig. 7 D). Importantly, the percentage of SIRPalpha+CD103- DCs was specifically and significantly reduced by CD47-Fc treatment (Fig. 7 E). On day 4, IL-17 and IFN-gamma mRNA expression were unaffected. After reinduction, IL-17 mRNA expression was effectively suppressed by CD47-Fc, whereas IFN-gamma mRNA expression was unaltered (Fig. 7 F). Regardless of the time of sacrifice (day 4 or after reinduction), the IL-17/IFN-gamma mRNA ratio was nearly identical and equally suppressed by administration of CD47-Fc (Fig. 7 G). Similarly, the Th17/Th1 ratio in mLNs was also reduced by CD47-Fc (unpublished data). We therefore conclude that CD47-Fc treatment protects mice from the development of chronic colitis and is correlated with an altered development of SIRPalpha+CD103- DC-mediated Th17 responses.
###end p 32
###begin p 33
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Administration of CD47-Fc protects BALB/c mice from the development of TNBS colitis.</bold>
###xml 480 481 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 487 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 522 524 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Administration of CD47-Fc protects BALB/c mice from the development of TNBS colitis. WT BALB/c mice were injected i.p. with saline or CD47-Fc, TNBS colitis was induced on days 0 and 8 (circles), and mice were sacrificed on day 4 or 12 (after reinduction). (A) Weight-loss curves normalized to body weight on day 0. (B) Macroscopic appearance and (C) mean macroscopic score inflammation. (D) Serum concentration (top) and colonic mRNA expression (bottom) of IL-6. (E) mLN SIRPalpha+CD103- DCs as a percentage of total CD11cHi. (F) Colonic mRNA expression of IL-17 and IFN-gamma. (G) IL-17/IFN-gamma mRNA expression ratio. Data represent means +/- SEM of more than six mice per group of two independent experiments. *, P < 0.05; **, P < 0.01.
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 261 262 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 267 268 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 527 528 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 533 534 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 741 742 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 747 748 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 850 851 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 888 889 872 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1111 1112 1091 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1117 1118 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1201 1202 1177 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1207 1208 1183 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
DCs lie at the interface between the innate and the adaptive immune system, and although they are poised to maintain gut homeostasis and tolerance, they also appear to play a critical role in CD pathogenesis. In this paper, we propose SIRPalpha-expressing CD11b+CD103- DCs as one primary candidate for the induction and perpetuation of chronic TNBS colitis and implicate CD47 as a key player in controlling their homeostasis and trafficking to the LP and mLNs. We first observed a correlation between the frequency of SIRPalpha+CD103- DCs in the LP and mLNs, Th17 responses, and the development of intestinal inflammation, parameters that were all impaired in CD47 KO mice. Next, we demonstrated that CD47 expression is required on SIRPalpha+CD103- DCs for efficient trafficking to mLNs and induction of severe wasting Th17-associated disease in vivo, but is dispensable on both SIRPalpha+ DCs and T cells to promote Th17 responses in vitro. Finally, early administration of a CD47-Fc molecule treated and prevented the recurrence of experimental colitis, which was correlated with defective homing of SIRPalpha+CD103- DCs and Th17 responses. We thus provide evidence that CD47 expression on SIRPalpha+CD103- DCs governs their trafficking and DC-driven Th17 responses, which are likely implicated in the development of intestinal inflammation.
###end p 35
###begin p 36
###xml 98 122 98 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Coombes and Powrie, 2008</xref>
###xml 333 334 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 489 490 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 495 496 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 612 613 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 671 672 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 781 782 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 944 945 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 950 951 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1074 1075 1058 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1154 1155 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1160 1161 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1302 1303 1278 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1308 1309 1284 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1451 1452 1427 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1503 1504 1479 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1709 1710 1685 1686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1716 1737 1692 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Jaensson et al., 2008</xref>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
###xml 1621 1629 <span type="species:ncbi:9606">patients</span>
Although the importance of DCs in the initiation of intestinal inflammation is now well accepted (Coombes and Powrie, 2008), the specific contributions of individual DC subsets and the key molecules involved in their function/migration remain to be clarified. This is the first study to identify SIRPalpha expression on mucosal CD103- DCs and to support a role for this DC subset in the in vivo promotion of intestinal inflammation. Nevertheless, although the proportion of total SIRPalpha+CD103- DCs increased in the LP and mLNs of WT mice upon induction of TNBS colitis, the percentage of the tolerogenic CD103+ DC subset, which we describe as being primarily SIRPalpha-, decreased in the mLNs. Therefore, it may have been postulated that the reduction in the proportion of CD103+ DCs migrating to the mLNs of WT mice was the key event in triggering intestinal inflammation, as opposed to the increased recruitment of the pathogenic SIRPalpha+CD103- DC subset in both the tissues and mLNs. Yet, CD47 KO mice do not display any change in the proportion of tolerogenic CD103+ DCs in mLNs upon exposure to TNBS, and a single administration of WT SIRPalpha+CD103- DCs in CD47 KO mice was sufficient to induce severe wasting disease. Consequently, our data support a proinflammatory role for the SIRPalpha+CD103- DC subset, the effect of which may be amplified by, but is not exclusively dependent on, the reduction in the proportion of tolerogenic CD103+ DCs in the mLNs. In support of this concept, CD103+ DCs are found in equal proportions in the mLNs draining the small intestines of healthy individuals and those of CD patients, implying that intestinal inflammation is not dependent on a reduction in CD103+ DCs (Jaensson et al., 2008).
###end p 36
###begin p 37
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 90 73 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Jang et al., 2006</xref>
###xml 92 110 92 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib67">Worbs et al., 2006</xref>
###xml 240 241 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 287 303 283 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 345 346 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 569 570 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 721 737 709 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 825 826 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 831 832 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1030 1031 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1036 1037 1016 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
In the gut, CCR7 largely controls CD103+ DC trafficking at steady state (Jang et al., 2006; Worbs et al., 2006). We have previously reported that the absence of CD47 does not alter CCR7 expression or the in vitro migration of skin SIRPalpha+ DCs toward CCL19 or sphingosine-1-phosphate (Van et al., 2006). The reduced proportion of the SIRPalpha+CD103- DC subset in the mLNs of CD47 KO and CD47-Fc-treated mice upon exposure to TNBS strongly suggests that CD47 promotes this process. These findings corroborate previous in vivo studies in which a reduction of SIRPalpha+ DCs was observed in skin-draining LNs of CD47 KO and CD47-Fc-treated mice, which was found to be independent of CD47 expression on lymphatic vessels (Van et al., 2006). In support of these findings, we demonstrate in this paper that injected WT SIRPalpha+CD103- DCs migrate more efficiently to mLNs and elicit a more aggressive form of disease in CD47 KO hosts when compared with CD47 KO DCs. However, the underlying mechanisms by which CD47 governs SIRPalpha+CD103- DC migration remains to be elucidated. One hypothesis is that CD47-SIRPalpha interactions that may occur in cis on the DC indirectly control integrin-mediated transendothelial trafficking.
###end p 37
###begin p 38
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 39 69 39 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Johansson-Lindbom et al., 2005</xref>
###xml 145 166 145 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Jaensson et al., 2008</xref>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 401 402 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 408 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 561 562 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 567 568 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 720 721 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 726 727 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 875 876 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 879 882 867 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 885 889 873 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 894 895 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 899 900 887 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 915 919 903 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 977 995 965 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib66">Varol et al., 2007</xref>
###xml 1114 1133 1102 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Nakano et al., 2009</xref>
###xml 1227 1228 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1233 1234 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1330 1331 1310 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1336 1337 1316 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1493 1494 1469 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1499 1500 1475 1476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1608 1609 1580 1581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1614 1615 1586 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 1387 1391 <span type="species:ncbi:10090">mice</span>
The expression of CD62L on CD103- DCs (Johansson-Lindbom et al., 2005) and a more recent report examining the turnover of intestinal DC subsets (Jaensson et al., 2008) favor the hypothesis of a direct recruitment of CD103- DCs or their precursors from the bloodstream to the mLNs via high endothelial venules at steady state. Our study supports this hypothesis, because there is no defect of SIRPalpha+CD103- DCs in the LP, whereas there is a significant reduction in the proportion of these DCs in the mLNs of CD47 KO mice at steady state. Therefore, SIRPalpha+CD103- DCs or their precursors may bypass the LP to seed the mLNs in a CD47-dependent manner. However, during the induction of colonic inflammation, SIRPalpha+CD103- DCs or their precursors may be recruited de novo to inflamed tissues before migrating to the mLNs. Interestingly, under inflammatory conditions, CX3CR1intGR1highCD62L+CCR2+ monocytes (GR1high monocytes) have been shown to differentiate into LP DCs (Varol et al., 2007), but i.v.-injected bone marrow monocytes are also capable of directly entering LNs through high endothelial venules (Nakano et al., 2009). Thus, under inflammatory conditions, CD47 may be implicated in the recruitment of SIRPalpha+CD103- DC precursors to the LP and/or the mLNs, resulting in a reduction in the frequency of SIRPalpha+CD103- DCs at those sites in CD47 KO or CD47-Fc-treated mice. Nevertheless, we cannot exclude the possibility that CD47 is required for the migration of SIRPalpha+CD103- DCs directly from the LP to the mLNs (). Thus, further examination of the physiological routes of SIRPalpha+CD103- DC trafficking under inflammatory conditions is required to delineate the precise role of CD47 in this process.
###end p 38
###begin p 39
###xml 187 208 187 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Fiorucci et al., 2002</xref>
###xml 210 231 210 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Katakura et al., 2005</xref>
###xml 243 244 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 369 388 365 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Cooper et al., 1995</xref>
###xml 800 817 796 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">K&#252;hl et al., 2007</xref>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
The early phases of TNBS colitis have been successfully induced in the absence of T cells. Therefore, innate-mediated mechanisms are also likely to be implicated in disease pathogenesis (Fiorucci et al., 2002; Katakura et al., 2005). SIRPalpha+ neutrophils, which are rapidly recruited to sites of inflammation, have been shown to exhibit CD47-mediated transmigration (Cooper et al., 1995). A significant reduction in colonic myeloperoxidase activity, a marker of neutrophil infiltration, occurred early in disease development in CD47 KO mice (unpublished data). We thus hypothesized that a defect in CD47-mediated neutrophil transmigration may be protective in the acute phase of disease. However, a previously published report has suggested a protective role for neutrophils in disease initiation (Kuhl et al., 2007). Therefore, although a reduction of neutrophil infiltration was observed in CD47 KO mice, we largely excluded this phenomenon as playing a protective role in the development of TNBS colitis.
###end p 39
###begin p 40
###xml 94 95 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 101 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 266 268 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 277 278 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 284 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 341 343 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hi</sup>
###xml 345 346 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 348 349 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 349 350 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 438 458 430 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Denning et al., 2007</xref>
###xml 597 617 581 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Neurath et al., 1995</xref>
###xml 619 641 603 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Parronchi et al., 1997</xref>
###xml 916 935 900 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Fujino et al., 2003</xref>
###xml 937 957 921 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Schmidt et al., 2005</xref>
###xml 1075 1093 1059 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Duerr et al., 2006</xref>
###xml 1301 1319 1282 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Jarry et al., 2008</xref>
###xml 1321 1341 1302 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">Zeuthen et al., 2008</xref>
###xml 1564 1581 1545 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Hart et al., 2005</xref>
###xml 1583 1603 1564 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Rimoldi et al., 2005</xref>
###xml 1737 1738 1715 1716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1753 1754 1731 1732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1794 1812 1772 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Iliev et al., 2009</xref>
###xml 1880 1899 1858 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Becker et al., 2003</xref>
###xml 2524 2542 2498 2516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib69">Zhang et al., 2006</xref>
###xml 2703 2724 2665 2686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Camoglio et al., 2000</xref>
###xml 2726 2745 2688 2707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">Tozawa et al., 2003</xref>
###xml 2945 2967 2899 2921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter hepaticus</italic>
###xml 3002 3023 2956 2977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Kullberg et al., 2006</xref>
###xml 3107 3125 3061 3079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Luger et al., 2008</xref>
###xml 3230 3251 3184 3205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Bettelli et al., 2004</xref>
###xml 3253 3273 3207 3227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Kroenke et al., 2008</xref>
###xml 3275 3296 3229 3250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Stromnes et al., 2008</xref>
###xml 3388 3389 3342 3343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3405 3406 3359 3360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3415 3416 3365 3366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3488 3511 3438 3461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Annunziato et al., 2007</xref>
###xml 3623 3645 3573 3595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Kobayashi et al., 2008</xref>
###xml 3827 3843 3773 3789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Lee et al., 2009</xref>
###xml 4419 4438 4365 4384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Mudter et al., 2008</xref>
###xml 791 797 <span type="species:ncbi:9606">humans</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
###xml 1369 1377 <span type="species:ncbi:9606">patients</span>
###xml 1869 1874 <span type="species:ncbi:10090">mouse</span>
###xml 2255 2259 <span type="species:ncbi:10090">mice</span>
###xml 2285 2289 <span type="species:ncbi:10090">mice</span>
###xml 2369 2373 <span type="species:ncbi:10090">mice</span>
###xml 2602 2606 <span type="species:ncbi:10090">mice</span>
###xml 2611 2615 <span type="species:ncbi:10090">mice</span>
###xml 2697 2701 <span type="species:ncbi:10090">mice</span>
###xml 2945 2967 <span type="species:ncbi:32025">Helicobacter hepaticus</span>
###xml 3330 3338 <span type="species:ncbi:9606">patients</span>
###xml 3778 3783 <span type="species:ncbi:10090">mouse</span>
In the present study, we observed causative links between an increased percentage of SIRPalpha+CD103- DCs, Th17-skewed responses, and disease manifestation, suggesting a role for Th17 cells in the development of colitis. The in vitro Th17-promoting capacity of CD11cHiSIRPalpha+CD103- DCs seems to be shared by the previously described CD11cHiCX3CR1+CD103- LP DC subset, supporting their contribution in the initiation of Th17 responses (Denning et al., 2007). Until recently, both CD and TNBS colitis have been considered Th1 diseases characterized by IL-12, TNF-alpha, and IFN-gamma production (Neurath et al., 1995; Parronchi et al., 1997). However, several recent observations have strongly implicated a role for IL-23, a Th17 survival factor, and Th17 cells in disease pathogenesis. In humans, elevated serum levels of IL-17 and colonic mucosal levels of both IL-17 and IL-23 have been detected in CD patients (Fujino et al., 2003; Schmidt et al., 2005), whereas a mutation in the IL-23R gene (rs11209026, c.1142G>A, p.Arg381Gln) is protective from disease development (Duerr et al., 2006). It is established that the intestinal mucosal environment, via TGF-beta, thymic stromal lymphopoietin, and IL-10, acts to condition resident antigen-presenting cells to exert immunosuppressive activities (Jarry et al., 2008; Zeuthen et al., 2008). Epithelial cells from CD patients express less thymic stromal lymphopoietin, leading to an enhanced release of the pro-Th1 and -Th17 inflammatory cytokines IL-12, IL-6, and IL-23, and expression of TLR2 and TLR4 by DCs (Hart et al., 2005; Rimoldi et al., 2005). Moreover, the combination of intestinal epithelial-derived TGF-beta and retinoid acid has also recently been shown to convert CD103- DCs into CD103+ DCs capable of generating T reg cells (Iliev et al., 2009). IL-23 is abundantly produced by ileal but not colonic mouse DCs (Becker et al., 2003). Therefore, TNBS colitis, a model in which the inflammation is localized to the colon, might be less suitable than others for examining IL-23 regulation, as underscored by the low colonic mRNA expression of IL-23p19 in this study, even under conditions of severe inflammation. Nonetheless, the expression of IL-17 was strongly up-regulated by TNBS in WT mice as compared with CD47 KO mice. IL-17 is considered to be pathogenic in TNBS colitis because IL-17R-deficient mice are protected from disease development, and administration of an anti-IL-17 mAb ameliorates intestinal inflammation despite high levels of IFN-gamma (Zhang et al., 2006). In contrast, IFN-gamma receptor- and IFN-gamma-deficient mice, or mice administered a neutralizing anti-IFN-gamma mAb developed colitis as severe as WT mice (Camoglio et al., 2000; Tozawa et al., 2003), suggesting that IFN-gamma and IL-12 play a less essential role in disease development than once believed. On the other hand, both IL-17 and IFN-gamma synergize to create intestinal inflammation in Helicobacter hepaticus-induced T cell-dependent colitis (Kullberg et al., 2006). In Th17-associated autoimmune diseases, such as experimental autoimmune uveitis (Luger et al., 2008) and experimental autoimmune encephalomyelitis, either Th1 or Th17 cells alone can drive tissue damage (Bettelli et al., 2004; Kroenke et al., 2008; Stromnes et al., 2008). T cell clones isolated from CD patients have been identified as being either single IL-17+ or double IL-17+IFN-gamma+ cells, underscoring the potentially pathogenic role of both cytokines (Annunziato et al., 2007). Some studies have even suggested a differential role for Th1 versus Th17 cells at various stages of disease (Kobayashi et al., 2008). Moreover, the developmental plasticity of Th17 cells has been reported, whereby IL-23 and IL-12 convert terminally differentiated mouse Th17 cells into IFN-gamma-producing cells (Lee et al., 2009). Thus, it is likely an oversimplification to implicate Th17 cells alone in the development of TNBS colitis, and as such, we monitored the Th17/Th1 ratio rather than an exclusive decrease in the frequency of Th17 cells as a common thread of disease protection throughout this study. Finally, although Th17 cells are often categorized as pathogenic in autoimmune disease, it should be emphasized that they critically participate in protecting the host from microbial invasion and maintaining the epithelial barrier, as was demonstrated for the Th17-associated cytokine IL-22 (Mudter et al., 2008).
###end p 40
###begin p 41
###xml 232 251 232 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Atreya et al., 2000</xref>
###xml 253 274 253 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">te Velde et al., 2007</xref>
###xml 359 378 359 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Atreya et al., 2000</xref>
###xml 380 396 380 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Gay et al., 2006</xref>
###xml 604 621 604 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Dann et al., 2008</xref>
###xml 623 642 623 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Mudter et al., 2008</xref>
###xml 741 742 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 747 748 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
We also report that the mRNA expression of IL-6, a key Th17 cell differentiation factor, was impaired in the colon tissues of protected mice. IL-6 plays an important role in both T cell-dependent and -independent models of colitis (Atreya et al., 2000; te Velde et al., 2007), and IL-6-deficient mice were reported to show resistance to TNBS-induced colitis (Atreya et al., 2000; Gay et al., 2006). Although the precise cellular source of IL-6 was not examined in this study, epithelial cells and T cells themselves, in addition to antigen-presenting cells, contribute to IL-6 production during colitis (Dann et al., 2008; Mudter et al., 2008). We demonstrate in this paper that CD47 expression does not regulate IL-6 production by SIRPalpha+CD103- DCs. Therefore, the reduction of IL-6 expression observed in this study likely reflects an indirect consequence of reduced tissue infiltration.
###end p 41
###begin p 42
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 119 135 119 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Van et al., 2008</xref>
###xml 163 187 163 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Bouguermouh et al., 2008</xref>
###xml 502 503 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 509 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 715 716 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 720 721 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 726 727 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1153 1174 1145 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">te Velde et al., 2006</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
To eliminate the developmental alterations in CD47 KO mice, such as the expansion of the CD103+ T reg cell population (Van et al., 2008) and Th1-biased phenotype (Bouguermouh et al., 2008), as a potential explanation for disease resistance, we demonstrate that the short-term interruption of CD47 ligation by the administration of a CD47-Fc molecule protected WT BALB/c mice from disease development. At an early time point after disease induction, we readily observed a reduced proportion of SIRPalpha+CD103- DCs in the mLNs and an inverted IL-17/IFN-gamma mRNA ratio in treated compared with untreated mice. The therapeutic efficacy of CD47-Fc could not be attributed to increased T reg cell activity, because CD4+CD25+FoxP3+ T reg cell numbers were positively correlated with inflammation and were lower in CD47-Fc-treated mice (unpublished data). Finally, early administration of CD47-Fc was shown to be highly effective in preventing both disease initiation and the recurrence of colitis after a second TNBS challenge. In that respect, the therapeutic efficacy of most published compounds has only been assessed in the prevention of acute disease (te Velde et al., 2006).
###end p 42
###begin p 43
###xml 43 44 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 49 50 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 221 222 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 227 228 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
In conclusion, we have identified SIRPalpha+CD103- DCs as an immunogenic Th17-inducing DC subset and propose their role in the pathogenesis of TNBS-induced colitis. We further demonstrate that CD47 expression on SIRPalpha+CD103- DCs promotes their trafficking and the development of severe intestinal inflammation. We therefore propose that targeting the CD47-SIRPalpha axis may serve as the basis for the development of novel therapeutic strategies in CD.
###end p 43
###begin title 44
MATERIALS AND METHODS
###end title 44
###begin title 45
Animals
###end title 45
###begin p 46
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
6-8-wk-old WT BALB/c and BALB/c CD47 KO mice were bred and maintained in our animal care facility in standard animal cages and under specific pathogen-free conditions. CD47 KO mice are viable and do not exhibit any overt phenotype. All mice were handled according to institutionally recommended animal care guidelines, and all experiments were approved by the Animal Studies Ethics Committee of McGill University and the Centre de Recherche du Centre Hospitalier de Montreal.
###end p 46
###begin title 47
Culture medium, antibodies, and reagents
###end title 47
###begin p 48
###xml 415 416 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 453 469 445 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 794 795 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 867 868 855 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 122 126 <span type="species:ncbi:9913">calf</span>
###xml 302 306 <span type="species:ncbi:9913">calf</span>
###xml 453 469 <span type="species:ncbi:562">Escherichia coli</span>
Ex vivo and in vitro experiments were performed using complete RPMI 1640 medium (Wisent Inc.) supplemented with 10% fetal calf serum (Wisent Inc), 500 U/ml penicillin, 500 microg/ml streptomycin, 10 mM Hepes buffer, and 1 mM 2-mercaptoethanol (Invitrogen). IMDM (Invitrogen) supplemented with 5% fetal calf serum, 500 U/ml penicillin, 500 microg/ml streptomycin, and 1 mM 2-mercaptoethanol was used for in vitro CD4+ T cell co-cultures with sorted DCs. Escherichia coli LPS was obtained from Sigma-Aldrich, and GM-CSF was purchased from PeproTech. The anti-CD3 antibody (145-2C11) used for in vitro polyclonal stimulation was obtained from BD. Allophycocyanin (APC)-labeled anti-CD4, FITC-labeled anti-IFN-gamma, and PE-labeled anti-IL-17 were used for intracytoplasmic cytokine staining of CD4+ T cells and were obtained from BD. For DC phenotype staining and DC/CD4+ T cell sorting, FITC-labeled anti-CD11b, anti-MHC II, anti-CD40, and anti-CD86, PE-labeled anti-SIRPalpha, biotinylated anti-CD103 plus streptavidin-PerCP, APC-labeled anti-CD11c, anti-CD45.2-APC-Cy7, and anti-CD4-PeCy7 were obtained from BD.
###end p 48
###begin title 49
TNBS-induced colitis
###end title 49
###begin p 50
###xml 227 252 223 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Scheiffele and Fuss, 2002</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">Mice</span>
###xml 592 596 <span type="species:ncbi:10090">Mice</span>
Two different models of chronic TNBS colitis were induced. In the first model, 3 mg TNBS (Sigma-Aldrich) was dissolved in 50% ethanol and a total volume of 50 microl was injected intrarectally in isopropanol-anesthetized mice (Scheiffele and Fuss, 2002). Controls included those administered intrarectal saline or ethanol alone. Mice were sacrificed 8 d after TNBS injection to assess colonic inflammation. The second form of chronic TNBS colitis was induced by two injections of 2 mg TNBS dissolved in 50% ethanol. The second injection was administered 7 or 8 d after the primary injection. Mice were sacrificed either 2 d after primary TNBS injection to assess early events in disease development or 4 d after the secondary injection to assess colonic inflammation.
###end p 50
###begin p 51
###xml 60 76 56 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 102 121 98 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Latour et al., 2001</xref>
###xml 728 746 724 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Ameho et al., 1997</xref>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
For treatment of TNBS colitis, 100 microg of mouse CD47-Fc (Van et al., 2006), control human CD47-Fc (Latour et al., 2001), or saline was injected i.p. on days 0-3, inclusively. 2 mg TNBS colitis was induced on days 0 and 8, and mice were sacrificed on day 4 or 12. In all cases, the macroscopic score of inflammation was assessed based on the degree of ulceration (0-10), the presence of diarrhea (0-1) and adhesions (0-2), and on the thickness of the colon wall (0-1). For histological assessment, colon samples were embedded in optimum cutting temperature compound (Sakura Finetek) and stained with hematoxylin and eosin. Histological changes were semiquantitatively graded based on a set of previously established criteria (Ameho et al., 1997). The grading scale ranged from 0-16 and was calculated as the sum of scores for expansion of submucosa (0-4), expansion of LP (0-4), loss of goblet cells (0-4), and neutrophil infiltration (0-4). All macroscopic and microscopic scoring was performed in a blinded fashion.
###end p 51
###begin title 52
Cytokine quantification by ELISA
###end title 52
###begin p 53
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
Whole blood was withdrawn from mice immediately postmortem and sera were frozen at -20degreesC until use. Serum IL-6 was quantified by the Quantikine ELISA kit (R&D Systems). IL-6 and IL-23p19 production was assessed in BMDC culture supernatants after overnight culture using the mouse IL-6 DuoSet (R & D Systems) and IL-23p19 (eBioscience) ELISA kits.
###end p 53
###begin title 54
Real-time PCR
###end title 54
###begin p 55
###xml 146 149 140 143 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zol</sc>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
Colons were immediately immersed in RNAlater (QIAGEN) upon dissection and frozen at -20degreesC until use. mRNA was extracted according to the TRIzol protocol and was reverse transcribed using the cDNA RT kit (Applied Biosystems). Quantitative real-time PCR was performed using a sequence detection system (1 PCR cycle at 95degreesC for 10 min; 40 PCR cycles at 60degreesC for 1 min and at 95degreesC for 15 s; ABI Prism 7900HT; Applied Biosystems). cDNA was amplified in a 10-microl final reaction mix containing TaqMan Universal PCR Master Mix (Applied Biosystems) and the corresponding TaqMan gene expression assays (IL-6, Mm00446190_m1; Eukaryotic 18s rRNA, Hs99999901_s1; IL-17a, Mm00439619_m1; IL-12p35, Mm00434165_m1; thrombospondin-1, Mm00449022_m1; IL-23p19, Mm00518984_m1; IFN-gamma, Mm00801778_m1; TGF-beta, Mm00441724_m1; Applied Biosystems). Signals were analyzed by the ABI Prism sequence detection system software (version 2.2; Applied Biosystems). The comparative Ct method for relative quantification was used, whereby all Ct were first normalized to the expression of 18s rRNA. Cytokine expression is represented as a fold change relative to control mice.
###end p 55
###begin title 56
Ex vivo cultures of mLNs
###end title 56
###begin p 57
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For ex vivo cultures, mLNs were harvested 3-4 d after secondary TNBS injection and 106 cells/ml were cultured in 48-well plates. Cells were stimulated with 2 microg/ml anti-CD3 antibody for 4 d in the presence of 20 ng/ml IL-23, followed by restimulation with 5 ng/ml PMA and 0.5 microg/ml ionomycin in the presence of 1 microg/ml Brefeldin A for the last 6 h of culture. In some experiments, cells were immediately stimulated after harvest with PMA/ionomycin in the presence of Brefeldin A. Cells were collected, stained for CD4, fixed and permeabilized with the Fix/Perm kit (BD), and stained for intracellular IL-17 and IFN-gamma for analysis by flow cytometry. Data were acquired on a FACSCalibur (BD) and were analyzed with CellQuest software (BD).
###end p 57
###begin title 58
DC phenotype in LP and mLNs
###end title 58
###begin p 59
###xml 48 67 48 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Drakes et al., 2004</xref>
###xml 329 330 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
LP cells were isolated as previously described (Drakes et al., 2004). In brief, colons were extracted, thoroughly cleaned, and digested in a solution of collagenase IV (Roche) and DNase I (Roche). mLNs were harvested 2 d after primary TNBS instillation and treated with 0.7 mg/ml Liberase (Roche) for 15 min at 37degreesC. 4 x 106 cells were stained with anti-CD45.2, anti-CD11c, anti-CD11b, anti-SIRPalpha, and anti-CD103 antibodies and analyzed by flow cytometry. Data were acquired on a FACSAria II (BD) and analyzed with CellQuest software.
###end p 59
###begin title 60
Generation of BMDCs
###end title 60
###begin p 61
###xml 63 79 63 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Van et al., 2006</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
BMDCs were generated from bone marrow as previously described (Van et al., 2006). In brief, bone marrow was harvested from WT and CD47 KO mice and cultured in RPMI 1640 supplemented with 5% FBS, 500 U/ml penicillin, 500 microg/ml streptomycin, 1 mM 2-mercaptoethanol, and 40 ng/ml GM-CSF, which was replenished on days 3, 7, and 12. BMDCs were harvested on day 13.
###end p 61
###begin title 62
In vitro and in vivo assessment of DC function
###end title 62
###begin title 63
In vitro.
###end title 63
###begin p 64
###xml 425 426 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 487 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 542 543 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 548 549 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 562 563 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 568 569 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 714 715 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
WT BALB/c mice were injected with 10 microg of human Flt3-L daily for 13 d to increase DC numbers. LP and mLN cells were purified as described, and cells were isolated from spleens using the same Liberase digestion protocol as mLNs. All cells were stained with anti-CD11b, anti-SIRPalpha, anti-CD103, anti-CD11c, anti-CD45.2, and anti-CD4, and sorted using a FACSAria II (Fig. S2 shows the gating strategy). The purity of CD4+ T cells and DC subsets was >99% and >96%, respectively. CD4+ T cells were co-cultured for 5 d with sorted SIRPalpha+CD103- or SIRPalpha-CD103+ DCs at a 25:1 ratio in the presence of soluble 2 microg/ml anti-CD3, 2 ng/ml TGF-beta, and 10 microg/ml anti-IFN-gamma. Transgenic (D011.10) CD4+ T cells were co-cultured with BMDCs (1:2 ratio) in the presence of 2 microg/ml OVA peptide, 2 ng/ml TGF-beta, and 10 microg/ml anti-IFN-gamma. On day 5, 5 ng/ml PMA, 0.5 microg/ml ionomycin, and 1 microg/ml Brefeldin A were added to the cell cultures, and intracytoplasmic staining for IL-17 and IFN-gamma was performed as described above.
###end p 64
###begin p 65
###xml 425 426 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 555 556 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
WT and CD47 KO BMDCs were stimulated with 100 ng/ml LPS and the expression of CD11c, CD11b, CD103, and SIRPalpha, and the activation markers CD86, CD40, and MHC II were assessed after overnight culture by flow cytometry. To assess cytokine production (IL-6 and IL-23p19), BMDCs were stimulated overnight with 100 ng/ml LPS in the presence of 10 ng/ml IFN-gamma. For WT/CD47 KO BMDC/T cell criss-cross co-cultures, splenic CD4+ T cells were purified using the EasySep Biotin Selection Kit (StemCell Technologies Inc.). Anti-CD3-stimulated (2 microg/ml) CD4+ T cells were co-cultured with LPS-stimulated (500 ng/ml) BMDCs at a 10:1 (T cell/DC) ratio in the presence of 1 ng/ml TGF-beta. After 5 d, cells were restimulated with PMA/ionomycin in the presence of Brefeldin A and stained for intracytoplasmic IL-17.
###end p 65
###begin title 66
In vivo.
###end title 66
###begin p 67
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 182 212 182 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Gonzalez-Rey and Delgado, 2006</xref>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
LPS-stimulated (500 ng/ml) WT and CD47 KO BMDCs were harvested and transferred to CD47 KO hosts by i.p. injection of 2 x 106 cells per mouse 30 min before induction of TNBS colitis (Gonzalez-Rey and Delgado, 2006).
###end p 67
###begin title 68
Competitive DC migration assay
###end title 68
###begin p 69
###xml 383 384 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
WT and CD47 KO BMDCs were stimulated with 500 ng/ml LPS overnight and labeled with CFSE (WT) or CMTMR (CD47 KO) and injected i.p. in CD47 KO hosts. TNBS colitis was induced 30 min after DC injection, and mLNs were harvested on day 2 from host mice to assess DC migration. mLNs were digested with 0.7 mg/ml Liberase for 15 min at 37degreesC, and cells were analyzed by gating on CD11c+ cells by flow cytometry.
###end p 69
###begin title 70
Statistical analyses
###end title 70
###begin p 71
###xml 145 146 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 160 161 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 185 186 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Statistical analyses were performed using the Instat program (GraphPad Software, Inc.). All values are expressed as means +/- SEM. The Student's t test, paired t test, and Mann-Whitney U test were used to assess statistical significance.
###end p 71
###begin title 72
Online supplemental material
###end title 72
###begin p 73
###xml 44 45 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 50 51 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 176 177 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 456 457 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 462 463 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 711 712 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 717 718 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 843 844 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 849 850 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
Fig. S1 indicates the frequency of SIRPalpha-CD103+ DCs in the LP and mLNs of WT and CD47 KO control mice or mice administered TNBS. Fig. S2 indicates the purity of DCs and CD4+ T cells isolated by cell sorting from mLNs of 10 pooled Flt3-L-treated mice. Fig. S3 demonstrates that WT BMDCs administered i.p. in WT mice has no effect on TNBS-induced colitis outcome (body weight loss and cytokine mRNA expression in colons). Fig. S4 indicates that SIRPalpha+CD103- DCs isolated from mLNs and injected i.p. into CD47 KO mice promote TNBS-induced colitis (body weight loss and macroscopic score) and Th17 responses in mLNs. Fig. S5 represents, in a schematic model, the potential routes of CD47-dependent SIRPalpha+CD103- DC or DC precursor migration to gut tissues and mLNs in response to TNBS administration, and the role of recruited SIRPalpha+CD103- DCs in the induction of Th17/Th1 polarization and perpetuation of colonic inflammation. Online supplemental material is available at .
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
[Supplemental Material]
###end title 75
###begin p 76
This work was supported by the Crohn's and Colitis Foundation of Canada (D. Franchimont, M. Sarfati, and G. Fortin), the Canada Research Chair (D. Franchimont), the Canadian Foundation for Innovation (D. Franchimont and M. Sarfati), and the Research Institute of the McGill University Health Centers (D. Franchimont). D. Franchimont is senior clinical scientist at the Belgium National Foundation for Research.
###end p 76
###begin p 77
The authors have no conflicting financial interests.
###end p 77
###begin article-title 78
Signal-regulatory protein is selectively expressed by myeloid and neuronal cells.
###end article-title 78
###begin article-title 79
Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis.
###end article-title 79
###begin article-title 80
###xml 38 43 <span type="species:ncbi:9606">human</span>
Phenotypic and functional features of human Th17 cells.
###end article-title 80
###begin article-title 81
###xml 40 45 <span type="species:ncbi:9606">human</span>
CD47 ligation selectively downregulates human interleukin 12 production.
###end article-title 81
###begin article-title 82
ATP drives lamina propria T(H)17 cell differentiation.
###end article-title 82
###begin article-title 83
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
###end article-title 83
###begin article-title 84
###xml 54 59 <span type="species:ncbi:9606">human</span>
CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors.
###end article-title 84
###begin article-title 85
Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
###end article-title 85
###begin article-title 86
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.
###end article-title 86
###begin article-title 87
Th17: the third member of the effector T cell trilogy.
###end article-title 87
###begin article-title 88
CD47 expression on T cell is a self-control negative regulator of type 1 immune response.
###end article-title 88
###begin article-title 89
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
###end article-title 89
###begin article-title 90
Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells.
###end article-title 90
###begin article-title 91
The genetics and immunopathogenesis of inflammatory bowel disease.
###end article-title 91
###begin article-title 92
Dendritic cells in intestinal immune regulation.
###end article-title 92
###begin article-title 93
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.
###end article-title 93
###begin article-title 94
Transendothelial migration of neutrophils involves integrin-associated protein (CD47).
###end article-title 94
###begin article-title 95
IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.
###end article-title 95
###begin article-title 96
Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.
###end article-title 96
###begin article-title 97
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Isolation and purification of colon lamina propria dendritic cells from mice with colitis.
###end article-title 97
###begin article-title 98
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
###end article-title 98
###begin article-title 99
Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis.
###end article-title 99
###begin article-title 100
Increased expression of interleukin 17 in inflammatory bowel disease.
###end article-title 100
###begin article-title 101
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
###end article-title 101
###begin article-title 102
Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
###end article-title 102
###begin article-title 103
Characteristics of intestinal dendritic cells in inflammatory bowel diseases.
###end article-title 103
###begin article-title 104
Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.
###end article-title 104
###begin article-title 105
Mucosal dendritic cells.
###end article-title 105
###begin article-title 106
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 113 119 <span type="species:ncbi:9606">humans</span>
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.
###end article-title 106
###begin article-title 107
CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes.
###end article-title 107
###begin article-title 108
###xml 112 117 <span type="species:ncbi:9606">human</span>
Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.
###end article-title 108
###begin article-title 109
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.
###end article-title 109
###begin article-title 110
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.
###end article-title 110
###begin article-title 111
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
###end article-title 111
###begin article-title 112
Innate and adaptive mechanisms to control pathological intestinal inflammation.
###end article-title 112
###begin article-title 113
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
###end article-title 113
###begin article-title 114
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
###end article-title 114
###begin article-title 115
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.
###end article-title 115
###begin article-title 116
Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils.
###end article-title 116
###begin article-title 117
###xml 26 48 26 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter hepaticus</italic>
###xml 26 48 <span type="species:ncbi:32025">Helicobacter hepaticus</span>
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.
###end article-title 117
###begin article-title 118
###xml 37 42 <span type="species:ncbi:9606">human</span>
Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation.
###end article-title 118
###begin article-title 119
Late developmental plasticity in the T helper 17 lineage.
###end article-title 119
###begin article-title 120
Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
###end article-title 120
###begin article-title 121
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
###end article-title 121
###begin article-title 122
###xml 82 86 <span type="species:ncbi:10090">mice</span>
The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.
###end article-title 122
###begin article-title 123
Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses.
###end article-title 123
###begin article-title 124
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
###end article-title 124
###begin article-title 125
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
###end article-title 125
###begin article-title 126
Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization.
###end article-title 126
###begin article-title 127
Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells.
###end article-title 127
###begin article-title 128
Gene therapy to target dendritic cells from blood to lymph nodes.
###end article-title 128
###begin article-title 129
Role of cytokines in inflammatory bowel disease.
###end article-title 129
###begin article-title 130
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Induction of TNBS colitis in mice.
###end article-title 130
###begin article-title 131
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
###end article-title 131
###begin article-title 132
The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
###end article-title 132
###begin article-title 133
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
###end article-title 133
###begin article-title 134
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.
###end article-title 134
###begin article-title 135
###xml 46 52 <span type="species:ncbi:10090">murine</span>
Critical appraisal of the current practice in murine TNBS-induced colitis.
###end article-title 135
###begin article-title 136
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
###end article-title 136
###begin article-title 137
Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow.
###end article-title 137
###begin article-title 138
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
###end article-title 138
###begin article-title 139
Interleukin-12 and its role in the generation of TH1 cells.
###end article-title 139
###begin article-title 140
Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs.
###end article-title 140
###begin article-title 141
Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103.
###end article-title 141
###begin article-title 142
Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.
###end article-title 142
###begin article-title 143
Monocytes give rise to mucosal, but not splenic, conventional dendritic cells.
###end article-title 143
###begin article-title 144
Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells.
###end article-title 144
###begin article-title 145
Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta.
###end article-title 145
###begin article-title 146
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis.
###end article-title 146
###begin p 147
Abbreviations used: BMDC, bone marrow-derived DC; CD, Crohn's disease; LP, lamina propria; mLN, mesenteric lymph node; SIRPalpha, signal regulatory protein alpha; TLR, Toll-like receptor; TNBS, trinitrobenzene sulfonic acid.
###end p 147

